User profiles for Albert Smolenski

Albert Smolenski

University College Dublin
Verified email at ucd.ie
Cited by 7872

[HTML][HTML] Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle

…, C Cario-Toumaniantz, A Smolenski… - Journal of Biological …, 2000 - ASBMB
The potent vasodilator action of cyclic GMP-dependent protein kinase (cGK) involves
decreasing the Ca 2+ sensitivity of contraction of smooth muscle via stimulation of myosin light …

Distinct and specific functions of cGMP-dependent protein kinases

SM Lohmann, AB Vaandrager, A Smolenski… - Trends in biochemical …, 1997 - cell.com
cGMP-dependent protein kinases I and II conduct signals from widespread signaling systems.
Whereas the type I kinase mediates numerous effects of natriuretic peptides and nitric …

[HTML][HTML] Endothelial nitric-oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein …

E Butt, M Bernhardt, A Smolenski, P Kotsonis… - Journal of Biological …, 2000 - ASBMB
Endothelial nitric-oxide synthase (NOS-III) is defined as being strictly dependent on Ca 2+ /calmodulin
(CaM) for activity, although NO release from endothelial cells has been reported …

[HTML][HTML] Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal …

A Smolenski, C Bachmann, K Reinhard… - Journal of Biological …, 1998 - ASBMB
The development and functional analysis of a monoclonal antibody (16C2) are reported; the
antibody recognizes vasodilator-stimulated phosphoprotein (VASP; an established …

Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes

B Fiedler, SM Lohmann, A Smolenski… - Proceedings of the …, 2002 - National Acad Sciences
Recent investigation has focused on identifying signaling pathways that inhibit cardiac
hypertrophy, a major risk factor for cardiovascular morbidity and mortality. In this context, nitric …

Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction

…, A Warnholtz, M Bodenschatz, A Smolenski… - Circulation …, 2000 - Am Heart Assoc
Studies with cGMP-dependent protein kinase I (cGK-I)-deficient human cells and mice
demonstrated that cGK-I ablation completely disrupts the NO/cGMP pathway in vascular tissue, …

[HTML][HTML] COVID-19 induces a hyperactive phenotype in circulating platelets

…, L Weiss, S Cullen, S Kelliher, A Smolenski… - PLoS …, 2021 - journals.plos.org
Coronavirus Disease 2019 (COVID-19), caused by the novel Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2), has affected over 30 million globally to date. Although …

Membrane targeting of cGMP-dependent protein kinase is required for cystic fibrosis transmembrane conductance regulator Cl channel activation

AB Vaandrager, A Smolenski, BC Tilly… - Proceedings of the …, 1998 - National Acad Sciences
A recently cloned isoform of cGMP-dependent protein kinase (cGK), designated type II, was
implicated as the mediator of cGMP-provoked intestinal Cl − secretion based on its …

[HTML][HTML] Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase a from an …

…, S Herterich, J Geiger, A Smolenski… - Journal of Biological …, 2010 - ASBMB
Protein kinase A (PKA) activation by cAMP phosphorylates multiple target proteins in
numerous platelet inhibitory pathways that have a very important role in maintaining circulating …

YC-1 potentiates nitric oxide-and carbon monoxide-induced cyclic GMP effects in human platelets

A Friebe, F Müllershausen, A Smolenski, U Walter… - Molecular …, 1998 - ASPET
Nitric oxide (NO), the physiological activator of soluble guanylyl cyclase (sGC), induces
inhibitory effects on platelet activation via elevation of cGMP levels and stimulation of the cGMP-…